COBRE GRANT

Information

  • Research Project
  • 9747918
  • ApplicationId
    9747918
  • Core Project Number
    P20GM109025
  • Full Project Number
    5P20GM109025-05
  • Serial Number
    109025
  • FOA Number
    PAR-14-035
  • Sub Project Id
  • Project Start Date
    9/1/2015 - 9 years ago
  • Project End Date
    5/31/2020 - 4 years ago
  • Program Officer Name
    CALDWELL, SHEILA
  • Budget Start Date
    6/1/2019 - 5 years ago
  • Budget End Date
    5/31/2020 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    05
  • Suffix
  • Award Notice Date
    6/7/2019 - 5 years ago

COBRE GRANT

? DESCRIPTION (provided by applicant): The COBRE Center for Neurodegeneration and Translational Neuroscience (CNTN) is proposed by a coalition of Cleveland Clinic Lou Ruvo Center for Brain Health (LRCBH) in Las Vegas, NV and the University of Nevada Las Vegas (UNLV) to: 1) establish an independent and sustainable infrastructure for translational research that will create a rich and unique scientific environment; 2) provide a transformative research training experience for 3 junior investigators/Project Leaders working in the area of neurodegenerative disorders (NDD); and 3) advance understanding of Alzheimer's disease (AD) and Parkinson's disease (PD), the two most common NDD. The CNTN will consist of 3 cores and 3 projects plus internal and external advisory committees. The Administrative Core will lead the vision, administrative oversight, budgetary and reporting aspects of the center, and will support the formative and summative assessment processes. The Data Management and Statistics Core will provide the technical hardware and software for data management for all aspects of the CNTN as well as providing expert statistical input on project design, analysis and interpretation. The Clinical and Translational Research Core will establish a well-characterized cohort of healthy controls (HC) and patients with AD or PD for Projects 1 and 2 as well as other junior investigators attracted to the CNTN. Project 1 will investigate the resting state default mode network with functional Magnetic Resonance Imaging (fMRI) in patients with mild cognitive impairment (MCI), mild-moderate AD, and HC. Project 1 will also use a novel positron emission tomography ligand to investigate microglial activity in AD, PD, and HC. Project 2 will use fMRI and diffusion tensor imaging to study the biological underpinnings of cognitive impairment in PD. Project 3 investigates the role of GABA receptors in the control of microglial activity in animal models of AD. A multifaceted mentoring program provides both local scientific mentors and specialist scientific mentors to all junior investigators. COBRE funds complemented by institutional commitment from LRCBH will be used to hire an imaging expert who will serve as mentor for Projects 1 and 2 as well as strengthening the research environment.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    1610090
  • Indirect Cost Amount
    652845
  • Total Cost
    2262935
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:2262935\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CLEVELAND CLINIC FOUNDATION
  • Organization Department
  • Organization DUNS
    017730458; 809775336
  • Organization City
    CLEVELAND
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    441950001
  • Organization District
    UNITED STATES